Atlas Trials

Clinical Stage IVA Gastric Cancer AJCC v8

14 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Clinical Stage IVA Gastric Cancer AJCC v8

RecordFirmDate
Pembrolizumab and Lenvatinib for the Treatment of Advanced, Unresectable, or Metastatic Gastroesophageal Adenocarcinoma (NCT05041153)M.D. Anderson Cancer Center2022-02-14
Ramucirumab and Trifluridine/Tipiracil or Paclitaxel for the Treatment of Patients With Previously Treated Advanced Gastric or Gastroesophageal Junction Cancer (NCT04660760)Academic and Community Cancer Research United2021-06-16
Enhanced Outpatient Symptom Management to Reduce Acute Care Visits Due to Chemotherapy-Related Adverse Events (NCT05038254)M.D. Anderson Cancer Center2021-05-12
Short-Course Chemoradiotherapy Followed by Chemotherapy for the Treatment of Resectable Gastric Adenocarcinoma (NCT04523818)M.D. Anderson Cancer Center2020-08-11
Testing the Addition of Radiotherapy to the Usual Treatment (Chemotherapy) for Patients With Esophageal and Gastric Cancer That Has Spread to a Limited Number of Other Places in the Body (NCT04248452)ECOG-ACRIN Cancer Research Group2020-05-26
Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes (NCT04501913)City of Hope Medical Center2019-12-24
Paclitaxel for the Treatment of Gastric or Gastroesophageal Cancer (NCT04220827)M.D. Anderson Cancer Center2019-12-06
IRX-2, Cyclophosphamide, and Pembrolizumab in Treating Participants With Recurrent or Metastatic Gastric or Gastroesophageal Junction Cancer (NCT03918499)City of Hope Medical Center2019-04-19
Nivolumab, Ipilimumab and Chemoradiation in Treating Patients With Resectable Gastric Cancer (NCT03776487)M.D. Anderson Cancer Center2019-01-07
Pembrolizumab in Treating Patients With Metastatic or Unresectable Gastroesophageal Adenocarcinoma (NCT03395847)M.D. Anderson Cancer Center2018-02-09

Track Clinical Stage IVA Gastric Cancer AJCC v8 automatically

Every clearance here is in the API, with alerts when new ones post.